EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

90‐day oral toxicity study in rats of a protein‐rich powder derived from Xanthobacter sp. SoF1

Bean Choi iD, Róbert Glávits, Timothy S Murbach iD, John R Endres, Gábor Hirka, Ilona Pasics Szakonyiné

Journal of Applied Toxicology · 2024

DOI: 10.1002/jat.4663 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2024. Verfasst von Bean Choi und 5 weiteren Autor:innen. Beteiligte Einrichtung: AIBMR Life Sciences, Inc., Seattle, Washington, USA. Hauptthemen laut MEDLINE: No-Observed-Adverse-Effect Level, Powders, Rats, Wistar. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Solar Foods Oy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xanthobacter sp. SoF1 (SoF1) is an autotrophic hydrogen‐oxidizing bacteria that produces protein‐rich biomass and has potential to be an alternative protein source that is more environmentally sustainable than animal and plant derived proteins. A protein‐rich powder derived from SoF1 was the test material in a 90‐day repeated‐dose oral toxicity study to explore major toxic effects, demonstrate target organs, and provide an estimate of a no‐observed‐adverse‐effect level (NOAEL). Daily doses of 0 (vehicle only), 375, 750, and 1500 mg/kg bw/day of the test material were administered by gavage to 10 Han:WIST rats/sex/group. An additional group was administered 1290 mg/kg bw/day whey protein concentrate as positive control. No treatment‐related adverse effects were observed, and no target organs were determined after 90/91 days of consecutive administration of the test item. A NOAEL of 1500 mg/kg bw/day was determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

No-Observed-Adverse-Effect LevelPowdersRats, WistarAnimalsMaleFemaleAdministration, OralRatsDose-Response Relationship, DrugBacterial Proteins

Stichwörter der Autor:innen

NOAELXanthobacterhydrogen oxidizing bacteriamicrobial proteinsafetysingle cell proteintoxicity

Substanzen

PowdersBacterial Proteins

Autor:innen und Institutionen

  • AIBMR Life Sciences, Inc., Seattle, Washington, USA.
  • Toxi-Coop Zrt., Budapest, Hungary.

ORCID-Profile: Bean Choi, Timothy S Murbach

Förderung

  • Solar Foods Oy

Zitieren

APA

Choi, B., Glávits, R., Murbach, T. S., Endres, J. R., Hirka, G., & Szakonyiné, I. P. (2024). 90‐day oral toxicity study in rats of a protein‐rich powder derived from Xanthobacter sp. SoF1. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4663

Vancouver

Choi B, Glávits R, Murbach TS, Endres JR, Hirka G, Szakonyiné IP. 90‐day oral toxicity study in rats of a protein‐rich powder derived from Xanthobacter sp. SoF1. Journal of Applied Toxicology. 2024. doi:10.1002/jat.4663

BibTeX
@article{Choi2024,
  author = {Choi, Bean and Glávits, Róbert and Murbach, Timothy S and Endres, John R and Hirka, Gábor and Szakonyiné, Ilona Pasics},
  title = {90‐day oral toxicity study in rats of a protein‐rich powder derived from Xanthobacter sp. SoF1},
  journal = {Journal of Applied Toxicology},
  year = {2024},
  doi = {10.1002/jat.4663}
}
Kostenlos starten →